Role of thioredoxin-interacting protein in diseases and its therapeutic outlook

N Qayyum, M Haseeb, MS Kim, S Choi - International Journal of …, 2021 - mdpi.com
Thioredoxin-interacting protein (TXNIP), widely known as thioredoxin-binding protein 2
(TBP2), is a major binding mediator in the thioredoxin (TXN) antioxidant system, which …

The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance

AS Doghish, O Elazazy, HH Mohamed… - … -Research and Practice, 2023 - Elsevier
In recent years, microRNAs (miRNAs) have gained increased attention from researchers
around the globe. Although it is twenty nucleotides long, it can modulate several gene …

Exosomal microRNA signatures in multiple sclerosis reflect disease status

S Ebrahimkhani, F Vafaee, PE Young, SSJ Hur… - Scientific reports, 2017 - nature.com
Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system (CNS). There is currently no single definitive test for MS. Circulating …

Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure

M Lombardi, R Parolisi, F Scaroni, E Bonfanti… - Acta …, 2019 - Springer
Microglia are highly plastic immune cells which exist in a continuum of activation states. By
shaping the function of oligodendrocyte precursor cells (OPCs), the brain cells which …

Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis

K Kimura, H Hohjoh, M Fukuoka, W Sato, S Oki… - Nature …, 2018 - nature.com
Multiple sclerosis (MS) is a T cell-mediated autoimmune disease of the central nervous
system. Foxp3+ regulatory T (Treg) cells are reduced in frequency and dysfunctional in …

miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis

Z Pan, Q Shan, P Gu, XM Wang, LW Tai, M Sun… - Journal of …, 2018 - Springer
Abstract Background Chemokine CXC receptor 4 (CXCR4) in spinal glial cells has been
implicated in neuropathic pain. However, the regulatory cascades of CXCR4 in neuropathic …

Circulating miRNAs as potential biomarkers in Alzheimer's disease

D Galimberti, C Villa, C Fenoglio… - Journal of …, 2014 - content.iospress.com
Several micro (mi) RNA are deregulated in brain, cerebrospinal fluid (CSF), and
serum/plasma from patients with Alzheimer's disease (AD). The aim of the study was to …

Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease

H Ding, Z Huang, M Chen, C Wang, X Chen… - Parkinsonism & related …, 2016 - Elsevier
Background and objective Parkinson's disease (PD) is the second most common age-
related neurodegenerative disorder after Alzheimer's disease. The aim of this work was to …

Salivary microR‐153 and microR‐223 levels as potential diagnostic biomarkers of idiopathic Parkinson's disease

M Cressatti, L Juwara, JM Galindez… - Movement …, 2020 - Wiley Online Library
Background Parkinson's disease (PD) is the most common movement disorder among
adults, affecting 2% of the world population older than 65 years of age. No diagnostic …

[HTML][HTML] Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy

C Griñán-Ferré, A Bellver-Sanchis, A Guerrero… - Pharmacological …, 2024 - Elsevier
About 80% of brain disorders have a genetic basis. The pathogenesis of most
neurodegenerative diseases is associated with a myriad of genetic defects, epigenetic …